跳到正文
研踪PaperTrail
← 研踪 PaperTrail
正在查看已观测的 v1。查看最新 v2 →

arXiv:2611.05127 · v1

Towards Multi-Method Evaluation of AI in Health: Integrating Benchmarks, Autoraters, and Expert Evaluation

首次提交 2026-11-04 00:12
版本更新 2026-11-04 00:12
雷达观测 2026-11-04 23:39
arXiv ↗PDF ↗

摘要

General-purpose generative AI (GenAI) models are being rapidly adopted in healthcare, but they are challenging to assess with traditional evaluation frameworks. These conceptual, methodological, and practical challenges parallel decades of work in evaluating clinician and health system quality and safety. We describe the adaptation of methods from several fields, combined with emerging technical approaches, into a structured, multi-method evaluation framework designed to give well-rounded assessments of GenAI in health at scale. The approach first anchors evaluation to Critical User Journeys (CUJs) to help prioritize out of a large choice space, and maps these to a phased AI system lifecycle (base model development, product development, and post-deployment monitoring), since evaluation at each stage requires different methodological approaches. In this context, the approach then integrates three distinct evaluation methods (closed-question benchmarks, LLM-as-a-judge autoraters, and expert human review) across three core domains: accuracy, safety, and usefulness. Taken together, this approach provides a strategic framework for bridging the gap between benchmarking results and performance in the real world with the goal of supporting decision-making and accountability across development, procurement, and deployment for product teams, health systems, and regulators.

作者备注:16 pages, 1 figure, 2 tables

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

查看最新版本解读 →

版本差异

仅对比实际观测的元数据,不代表 PDF 正文或实验变化。版本可能不连续;带删除线为移除,下划线为新增。

作者变化

Sarah Montgomery-Taylor,Hamsa Subramaniam,Rob Brisk,Liam Foster,Jack Ching,Andrew Marshall,Jim Taylor,John Hernandez,Jen McKay,Dillon Obika,Nnamdi Ezeanochie,Nira Goren,Tiffany Guo,Rachel Kwon,Arlene Chung,Jacqueline Shreibati,Stella Yeoum,Brett Hatfield,Zelda Gulledge,Ankit Nathu,Ferenc Kazinczi,Yun Liu,Jonathan Krause,Heather Cole-Lewis,Susan Thomas,Megan Jones Bell,Bakul Patel,Joelle Barral,Katherine Chou,Yossi Matias,Dana Gelb Safran,Elizabeth A. McGlynn,Michael Howell

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v2 · 2026-11-05 02:33 · 最新观测版本

Towards Multi-Method Evaluation of AI in Health: Integrating Benchmarks, Autoraters, and Expert Evaluation

General-purpose generative AI (GenAI) models are being rapidly adopted in healthcare, but they are challenging to assess with traditional evaluation frameworks. These conceptual, methodological, and practical challenges parallel decades of work in evaluating clinician and health system quality and safety. We describe the adaptation of methods from several fields, combined with emerging technical approaches, into a structured, multi-method evaluation framework designed to give well-rounded assessments of GenAI in health at scale. The approach first anchors evaluation to Critical User Journeys (CUJs) to help prioritize out of a large choice space, and maps these to a phased AI system lifecycle (base model development, product development, and post-deployment monitoring), since evaluation at each stage requires different methodological approaches. In this context, the approach then integrates three distinct evaluation methods (closed-question benchmarks, LLM-as-a-judge autoraters, and expert human review) across three core domains: accuracy, safety, and usefulness. Taken together, this approach provides a strategic framework for bridging the gap between benchmarking results and performance in the real world with the goal of supporting decision-making and accountability across development, procurement, and deployment for product teams, health systems, and regulators.

查看此版本解读 →查看此版本原文 ↗
v1 · 2026-11-04 00:12

Towards Multi-Method Evaluation of AI in Health: Integrating Benchmarks, Autoraters, and Expert Evaluation

General-purpose generative AI (GenAI) models are being rapidly adopted in healthcare, but they are challenging to assess with traditional evaluation frameworks. These conceptual, methodological, and practical challenges parallel decades of work in evaluating clinician and health system quality and safety. We describe the adaptation of methods from several fields, combined with emerging technical approaches, into a structured, multi-method evaluation framework designed to give well-rounded assessments of GenAI in health at scale. The approach first anchors evaluation to Critical User Journeys (CUJs) to help prioritize out of a large choice space, and maps these to a phased AI system lifecycle (base model development, product development, and post-deployment monitoring), since evaluation at each stage requires different methodological approaches. In this context, the approach then integrates three distinct evaluation methods (closed-question benchmarks, LLM-as-a-judge autoraters, and expert human review) across three core domains: accuracy, safety, and usefulness. Taken together, this approach provides a strategic framework for bridging the gap between benchmarking results and performance in the real world with the goal of supporting decision-making and accountability across development, procurement, and deployment for product teams, health systems, and regulators.

查看此版本解读 →查看此版本原文 ↗